M. Cory Zwerling

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.

Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA.

Amerigroup Corp. provides health care coverage to people eligible for medicaid and children insurance program benefits. The company was founded by Jeffrey L. McWaters on December 9,1994 and is headquartered in Virginia Beach, VA.

Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs.

HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts.

Foley Hoag LLP provides legal services. It offers international litigation and arbitration services, and counsel in the evolving field of corporate social responsibility. The firm offers practices in industries such as life sciences, health care, technology, energy and renewable, investment management, and professional services. The company was founded in 1943 and is headquartered in Boston, MA.

Fabric Genomics, Inc. operates as an analytical genome interpretation company. It develops scalable and fully integrated informatics systems specifically design to interpret human genome sequences for research and clinical applications. The company was founded by by Martin G. Reese, Edward S. Kiruluta, John Stuelpnagel, and Paul Billings and is headquartered in Oakland, CA.

Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.

ASCEND Therapeutics US LLC operates as a specialty pharmaceutical company which focuses on women’s health. The firm develops and markets pharmaceutical transdermal therapies. Its products include EstroGel, a non-patch transdermal estrogen therapy. The company was founded by Jay A. Bua in 2002 and is headquartered in Herndon, VA.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland.

Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom.

Detect, Inc. is a medical device and biotechnology company. The company was founded by Jonathan Rothberg and is headquartered in Guilford, CT.

Sestina Bio LLC operates a platform for automated synthetic biology. It provides technology centric, R&D platform to provide cutting edge solutions to sustainably feed and clothe. The firms approach is to integrate tools for genome editing, single cell biology, and machine learning to transform ability to engineer and harness biological function. The company was founded by William Wayne Colston, Jr. and is headquartered in Pleasanton, CA.

Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA.

Alumis, Inc. manufactures and sells pharmaceutical products for neuroinflammatory, neurodegenerative, and immune diseases. The company is based in San Francisco, CA. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021.

Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters.